Media Summary: This talk is from the 2023 HHT Canada THH Virtual Patient Conference. Dr. Hanny Al-Samkari is an assistant Professor of ... Marina Garassino, MD; Enriqueta Felip, MD, PhD; Joachim G. Aerts, MD, PhD; and Roy S. Herbst, MD, PhD, describe the ... In this segment, Manish A. Shah, MD, talks about what is known in terms of mechanisms of action for
Bevacizumab And Antiangiogenic Therapies In - Detailed Analysis & Overview
This talk is from the 2023 HHT Canada THH Virtual Patient Conference. Dr. Hanny Al-Samkari is an assistant Professor of ... Marina Garassino, MD; Enriqueta Felip, MD, PhD; Joachim G. Aerts, MD, PhD; and Roy S. Herbst, MD, PhD, describe the ... In this segment, Manish A. Shah, MD, talks about what is known in terms of mechanisms of action for Mark A. Socinski, MD, leads the panelists, Edward Garon, MD; Roy S. Herbst, MD, PhD; Johanna Bendell, MD; and Manish A. Two angiogenesis inhibitors are effective in the second-line setting for patients with mCRC, which makes determining between ... In this segment, Robert A. Burger, MD, FACOG, FACS, and James Tate Thigpen, MD, discuss the use of
This video is part of the HMP Education content archive and may include previously accredited educational material. While this ... An expert oncologist discusses whether to use Dr. Howard A. "Skip" Burris III, editor-in-chief of The Oncology Report, and associate editors Dr. William J. Gradishar and Dr. Hope ... Panelists Bradley J. Monk, MD; Katie Moore, MD; Matthew A. Powell, MD; Gottfried E. Konecny, MD; and Robert L. Coleman, MD, ... Panelists Mark A. Socinski, MD; Edward Garon, MD; Roy S. Herbst, MD, PhD; Johanna Bendell, MD; Manish A. Shah, MD; and ... Expert panelists review considerations for combining
Dr. Jack West, Swedish Cancer Institute, discusses the
